|
1
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: A global and regional perspective. Oncologist. 15:(Suppl
4). 5–13. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hao K, Luk JM, Lee NP, Mao M, Zhang C,
Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, et al: Predicting
prognosis in hepatocellular carcinoma after curative surgery with
common clinicopathologic parameters. BMC Cancer. 9:3892009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen XM: MicroRNA signatures in liver
diseases. World J Gastroenterol. 15:1665–1672. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hampton T: MicroRNA and metastasis. JAMA.
298:1998. 2007. View Article : Google Scholar
|
|
9
|
Gramantieri L, Fornari F, Callegari E,
Sabbioni S, Lanza G, Croce CM, Bolondi L and Negrini M: MicroRNA
involvement in hepatocellular carcinoma. J Cell Mol Med.
12:2189–2204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ji J and Wang XW: New kids on the block:
Diagnostic and prognostic microRNAs in hepatocellular carcinoma.
Cancer Biol Ther. 8:1686–1693. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giordano S and Columbano A: MicroRNAs: New
tools for diagnosis, prognosis, and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Li X and Chen X: Prognostic
significance of tissue miR-345 downregulation in non-small cell
lung cancer. Int J Clin Exp Med. 8:20971–20976. 2015.PubMed/NCBI
|
|
13
|
Chen QG, Zhou W, Han T, Du SQ, Li ZH,
Zhang Z, Shan GY and Kong CZ: MiR-345 suppresses proliferation,
migration and invasion by targeting Smad1 in human prostate cancer.
J Cancer Res Clin Oncol. 142:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Srivastava SK, Bhardwaj A, Arora S, Tyagi
N, Singh S, Andrews J, McClellan S, Wang B and Singh AP:
MicroRNA-345 induces apoptosis in pancreatic cancer cells through
potentiation of caspase-dependent and -independent pathways. Br J
Cancer. 113:660–668. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Zender L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tschaharganeh DF, Chen X, Latzko P, Malz
M, Gaida MM, Felix K, Ladu S, Singer S, Pinna F, Gretz N, et al:
Yes-associated protein up-regulates Jagged-1 and activates the
Notch pathway in human hepatocellular carcinoma. Gastroenterology.
144:1530–1542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cho WC: MicroRNAs: Potential biomarkers
for cancer diagnosis, prognosis and targets for therapy. Int J
Biochem Cell Biol. 42:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Clin Chem. 55:623–631. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu J, Li N, Wang X, Ren H, Wang W, Wang S,
Song Y, Liu Y, Li Y, Zhou X, et al: Circulating serum microRNA-345
correlates with unfavorable pathological response to preoperative
chemoradiotherapy in locally advanced rectal cancer. Oncotarget.
7:64233–64243. 2016.PubMed/NCBI
|
|
21
|
Harvey KF, Zhang X and Thomas DM: The
Hippo pathway and human cancer. Nat Rev Cancer. 13:246–257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
